Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1983 Jan;36(1):24–29. doi: 10.1136/jcp.36.1.24

Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.

J Crocker, E L Jones
PMCID: PMC498099  PMID: 6401771

Abstract

Three cases of acute renal toxicity in patients receiving long-term therapy with mitomycin C and 5-fluorouracil are reported. Two of the patients (1 and 3) are from a multicentre trial of adjuvant chemotherapy for gastric carcinoma. All three cases showed extensive fibrin deposition in the kidneys and lungs, the appearances of the renal lesions being similar to those seen in the haemolytic-uraemic syndrome. Two of the three cases had received blood transfusions, and attention is drawn to the possibility that mitomycin C may sensitise the kidneys to minor mismatches. With the increasing use of these antimitotic agents, great vigilance should be exercised with regard to renal function and haemolytic status.

Full text

PDF
24

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brain M. C., Azzopardi J. G., Baker L. R., Pineo G. F., Roberts P. D., Dacie J. V. Microangiopathic haemolytic anaemia and mucin-forming adenocarcinoma. Br J Haematol. 1970 Feb;18(2):183–193. doi: 10.1111/j.1365-2141.1970.tb01433.x. [DOI] [PubMed] [Google Scholar]
  2. Fielding J. W., Crocker J., Stockley R. A., Brookes V. S. Interstitial fibrosis in a patient treated with 5-fluorouracil and mitomycin C. Br Med J. 1979 Sep 1;2(6189):551–552. doi: 10.1136/bmj.2.6189.551-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fielding J. W., Stockley R. A., Brookes V. S. Interstitial lung disease in a patient treated with 5-fluorouracil and mitomycin C. Br Med J. 1978 Aug 26;2(6137):602–602. doi: 10.1136/bmj.2.6137.602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hanna W. T., Krauss S., Regester R. F., Murphy W. M. Renal disease after mitomycin C therapy. Cancer. 1981 Dec 15;48(12):2583–2588. doi: 10.1002/1097-0142(19811215)48:12<2583::aid-cncr2820481208>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  5. Jones B. G., Fielding J. W., Newman C. E., Howell A., Brookes V. S. Intravascular haemolysis and renal impairment after blood transfusion in two patients on long-term 5-fluorouracil and mitomycin-C. Lancet. 1980 Jun 14;1(8181):1275–1277. doi: 10.1016/s0140-6736(80)91734-1. [DOI] [PubMed] [Google Scholar]
  6. Krauss S., Sonoda T., Solomon A. Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C. Cancer. 1979 May;43(5):1598–1603. doi: 10.1002/1097-0142(197905)43:5<1598::aid-cncr2820430505>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  7. Liu K., Mittelman A., Sproul E. E., Elias E. G. Renal toxicity in man treated with mitomycin C. Cancer. 1971 Nov;28(5):1314–1320. doi: 10.1002/1097-0142(1971)28:5<1314::aid-cncr2820280534>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  8. Lynch E. C., Bakken C. L., Casey T. H., Alfrey C. P., Jr Microangiopathic hemolytic anemia in carcinoma of the stomach. Gastroenterology. 1967 Jan;52(1):88–93. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES